U.S. Water Utilities Stock News

NYSE:KSS
NYSE:KSSMultiline Retail

Is Now The Moment To Reconsider Kohl's (KSS) After Its Sharp Share Price Slide

If you are wondering whether Kohl's current share price reflects its underlying value, you are not alone. Many investors are asking the same question. The stock last closed at US$15.38, with returns of a 13.2% decline over 7 days, a 12.0% decline over 30 days, a 27.9% decline year to date, a 40.9% gain over 1 year, a 29.1% decline over 3 years, and a 63.9% decline over 5 years. Recent headlines around Kohl's have focused on the company as a traditional department store operator in a highly...
NasdaqGS:HCSG
NasdaqGS:HCSGCommercial Services

Stronger Q4 Earnings and Analyst Coverage Might Change The Case For Investing In Healthcare Services Group (HCSG)

Recently, Healthcare Services Group reported strong fourth-quarter results with better-than-expected adjusted EBITDA, prompting RBC Capital to begin coverage and other analysts to reiterate their positive views on the company’s fundamentals. The latest analyst commentary highlights how improving skilled nursing facility economics and growing emphasis on clinical quality may support rising demand for Healthcare Services Group’s outsourced environmental and dietary services across U.S. care...
NYSE:BUR
NYSE:BURDiversified Financial

Burford Capital (BUR) Is Down 8.4% After Wider Q4 Loss But Higher Dividend - What's Changed

Burford Capital Limited has reported past fourth-quarter 2025 results showing revenue of US$33.41 million versus US$93.03 million a year earlier, swinging to a quarterly net loss of US$37.50 million and diluted loss per share of US$0.17, while its board also declared a final 2025 dividend of US$0.0625 per share, subject to shareholder approval. Despite weaker quarterly earnings, Burford highlighted a 39% rise in new definitive commitments and lifted its final 2025 dividend, underscoring...
NasdaqGS:SGRY
NasdaqGS:SGRYHealthcare

Surgery Partners (SGRY) Loss Narrows To US$0.12 EPS As Profitability Narrative Gains Traction

How Surgery Partners' FY 2025 Numbers Set Up the Next Phase of Its Story Surgery Partners (SGRY) has closed out FY 2025 with fourth quarter revenue of US$885 million and a basic EPS loss of US$0.12, alongside a full year trailing revenue base of about US$3.3 billion and a trailing EPS loss of US$0.61. The company has seen quarterly revenue move from US$770.4 million in Q3 2024 to US$821.5 million in Q3 2025 and US$885 million in Q4 2025. Over the same period, quarterly EPS moved from a loss...
NasdaqGM:WINA
NasdaqGM:WINASpecialty Retail

Assessing Winmark (WINA) Valuation After Earnings Show Growth In Sales Revenue And Net Income

Winmark (WINA) has put fresh numbers on the table, reporting fourth quarter and full year 2025 results that show higher sales, revenue, net income, and earnings per share compared with the prior year. See our latest analysis for Winmark. Those results land after a strong run in the shares, with the latest share price at $480.67 and a 90 day share price return of 11.74%, while the 1 year total shareholder return of 55.13% and 5 year total shareholder return of about 3x suggest momentum has...
NYSE:GGG
NYSE:GGGMachinery

Assessing Graco (GGG) Valuation After Oil Price Shock And Inflation Jitters

Graco (GGG) shares were caught up in a broader pullback after geopolitical tensions in the Middle East pushed crude oil prices higher, reviving inflation concerns and raising questions about interest rate timing for industrial names. See our latest analysis for Graco. Beyond today’s 2.5% decline in the share price, Graco’s recent news flow includes the launch of its Pulse Mobile fluid management system and an upcoming CFO transition. Its 30 day share price return of 5.86% and 90 day share...
NYSE:AXP
NYSE:AXPConsumer Finance

American Express Dividend Hike And New Tower Shape Long Term Story

American Express (NYSE:AXP) approved a 16% increase to its quarterly dividend. The company also announced plans to build a new global headquarters at 2 World Trade Center in Lower Manhattan. Both decisions highlight management’s capital allocation priorities and long term presence in New York City. American Express operates a global payments network and issues cards that target consumer, small business, and corporate spending. For investors, a higher dividend can change the mix of total...
NasdaqGS:PDD
NasdaqGS:PDDMultiline Retail

A Look At PDD Holdings (PDD) Valuation After Recent Share Price Weakness

Event context and recent share performance PDD Holdings (PDD) has been trading under pressure recently, with the stock down about 2% over the past day and roughly 6% over the past week as investors reassess sentiment around the business. See our latest analysis for PDD Holdings. Zooming out, the recent 1-day and 7-day share price declines fit into a weaker patch, with a 90-day share price return of 14.07% and a 1-year total shareholder return of 11.20%. This contrasts with a 7.52% total...
NYSE:WEC
NYSE:WECIntegrated Utilities

A Look At WEC Energy Group’s Valuation As It Upgrades Grid Connectivity With OneLayer Bridge

WEC Energy Group (WEC) is drawing fresh investor attention after adopting OneLayer Bridge to oversee cellular connected field devices across multiple carrier networks, a move tied to its broader digital infrastructure investments. See our latest analysis for WEC Energy Group. Against this operational backdrop, WEC Energy Group’s share price, last closing at $116.12, has posted a 4.92% 1 month share price return and 9.06% year to date share price return. Its 5 year total shareholder return of...
NYSE:WBS
NYSE:WBSBanks

Is Webster Financial (WBS) Pricing Reflect Its Regional Banking Reassessment And Valuation Gap

If you are wondering whether Webster Financial's current share price lines up with its underlying worth, or if the market is missing something, this article walks through the key numbers so you can judge the value for yourself. The stock last closed at US$68.77, with returns of 4.6% over 30 days, 7.8% year to date, 34.5% over 1 year, 51.8% over 3 years and 35.7% over 5 years, even after a 5.0% pullback over the past week. Recent news around Webster Financial has largely focused on the bank's...
NYSE:APO
NYSE:APODiversified Financial

Apollo Lawsuit Over Epstein Disclosures Puts Governance And Stock Under Scrutiny

A class action lawsuit has been filed alleging Apollo Global Management misled investors about its business relations with Jeffrey Epstein. The complaint claims senior leaders at Apollo communicated frequently with Epstein in the 2010s despite prior public denials. The suit names top executives and alleges material misstatements over several years regarding those interactions. For investors watching NYSE:APO, this lawsuit puts a spotlight on governance and disclosure practices at a time...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Acadia Healthcare Goodwill Impairment Resets Valuation And Earnings Picture

Acadia Healthcare Company (NasdaqGS:ACHC) recorded a substantial non cash goodwill impairment charge in Q4 2025. The impairment led to a significant net loss for both the quarter and the full year 2025. Operational growth continued through facility expansions and new joint ventures despite the non recurring charge. For investors watching Acadia Healthcare at a share price of $22.99, the goodwill impairment is a key development to factor into any assessment of the business. The stock has...
NasdaqCM:FMNB
NasdaqCM:FMNBBanks

Is Farmers National Banc (FMNB) Offering Long-Term Value At Around US$13 Per Share

Wondering if Farmers National Banc at around US$13.13 is quietly offering value, or if the market has it about right? This article walks through what the numbers are really saying about the stock. The share price has been fairly steady recently, with a 0.1% slip over the last 7 days, a 1.2% gain over 30 days, a 1.1% decline year to date, and a 0.2% return over the past year. The 3 year and 5 year returns sit at 13.8% and 2.2% respectively. Alongside these returns, investors have been...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Evaluating Intapp (INTA) After Celeste AI Platform Launch And New Anthropic And Harvey Partnerships

Intapp (INTA) has put agentic AI at the center of its story, launching the new Celeste platform and deepening collaborations with Anthropic’s Claude and Harvey to target tightly governed professional services workflows. See our latest analysis for Intapp. The recent product and partnership announcements have come alongside a sharp rebound in the share price, with an 11.5% 1 day share price return and 22.6% 7 day share price return. However, this follows a 42.1% 90 day share price decline and...
NYSE:RIG
NYSE:RIGEnergy Services

Transocean Valaris Deal Reshapes Offshore Backlog While Legal Risks Linger

Transocean (NYSE:RIG) announced an agreement to acquire Valaris, aiming to combine two major offshore drilling fleets. The deal is expected to increase Transocean's contract backlog and reinforce its position in the offshore drilling market. Legal investigations and shareholder concerns have emerged around the transaction, adding uncertainty around timing and final terms. Transocean focuses on offshore contract drilling services for oil and gas companies, and Valaris operates in the same...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Erie Indemnity CEO Retirement Puts Earnings And Dividend Outlook In Focus

Erie Indemnity (NasdaqGS:ERIE) announced the planned retirement of CEO Tim NeCastro. The company has begun a formal search process to identify NeCastro’s successor. The transition will mark the end of a long tenure that included major company milestones. For investors watching Erie Indemnity at a share price of $272.16, this leadership change comes after mixed recent returns. The stock is up 5.9% over the past week, while showing a 3.8% decline over 30 days and a 2.0% decline year to date...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics Milestone With Azer Cel Adds New Dimension To Growth Story

TG Therapeutics and Precision BioSciences reached a clinical milestone for azercabtagene zapreleucel (azer-cel) in a Phase 1 trial for progressive multiple sclerosis. The milestone is tied to early clinical progress in applying azer-cel, an allogeneic CAR T cell therapy, to autoimmune disease. This marks a step for TG Therapeutics in extending its pipeline beyond its core product into new neurological indications. TG Therapeutics, traded as NasdaqCM:TGTX, is drawing fresh attention as it...
NYSE:STZ
NYSE:STZBeverage

Constellation Brands 2026 Recovery Plan Meets Valuation And Debt Questions

Constellation Brands (NYSE:STZ) is targeting a business recovery in 2026 after a challenging year for the beverage alcohol sector. The company reports that it grew market share across 49 states during the broader industry downturn in 2025. Management is refocusing on growth initiatives and operational momentum as key priorities for the next phase. Constellation Brands, the owner of well known beer, wine, and spirits labels, is moving into 2026 with an emphasis on regaining momentum after a...
NYSE:RDDT
NYSE:RDDTInteractive Media and Services

Will Reddit's First Profitable Year and AI Data Push Change Reddit's (RDDT) Narrative

In late February 2026, Reddit reported past quarterly results showing strong year-over-year revenue and user growth, alongside its first full year of GAAP profitability and expanding AI-driven advertising, data licensing, and social commerce efforts. At the same time, the company’s slower near-term revenue growth guidance, public endorsement from Jim Cramer, and a reduction in short interest reshaped how investors evaluate Reddit’s longer-term business potential. Next, we’ll examine how...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Is It Time To Reassess Amgen (AMGN) After Its Strong Multi Year Share Price Run?

If you are wondering whether Amgen's current share price lines up with its underlying value, this article walks through the numbers so you can judge for yourself. Amgen recently closed at US$377.00, with returns of a 1.5% decline over 7 days, 10.3% over 30 days, 15.1% year to date, 24.5% over 1 year, 81.1% over 3 years and 92.6% over 5 years, which may catch the eye of investors thinking about growth potential and shifting risk perceptions. Recent headlines around Amgen have focused on its...
NYSE:MFA
NYSE:MFAMortgage REITs

Stronger Earnings and New US$200 Million Buyback Might Change The Case For Investing In MFA (MFA)

MFA Financial, Inc. recently reported that fourth-quarter 2025 net income rose to US$54.32 million, with basic earnings per share from continuing operations of US$0.42, and also authorized a new share repurchase program of up to US$200 million through the end of 2028. Alongside this earnings improvement, the board declared quarterly dividends on its Series B and Series C preferred shares, including a higher floating-rate payout on Series C that highlights the impact of current short-term...
NYSE:WMB
NYSE:WMBOil and Gas

Is Williams Companies (WMB) Pricing In Too Much Optimism After Its 1 Year 38% Rally

If you are wondering whether Williams Companies shares still offer value after a strong run, this article walks through what the current price might be implying about the business. The stock last closed at US$75.88, with returns of 3.2% over 7 days, 12.8% over 30 days, 24.7% year to date and 38.2% over 1 year. This naturally raises questions about how much optimism is already in the price. Recent news around Williams has focused on its role in US energy infrastructure and longer term natural...
NasdaqGM:EXPI
NasdaqGM:EXPIReal Estate

eXp World Expands Data Tools And European Reach While Managing Losses

eXp World Holdings (NasdaqGM:EXPI) agreed a partnership with Land id to expand its property data capabilities. The company is extending its international footprint into Romania and the Netherlands, with Luxembourg expected to follow. These updates relate to eXp’s digital real estate platform and global brokerage operations. eXp World Holdings runs a cloud based real estate brokerage and related digital services, so data quality and geographic reach are central to its business model. The...
NYSE:CW
NYSE:CWAerospace & Defense

Curtiss-Wright Wins New Defense Work As Valuation Stays Elevated

Curtiss-Wright (NYSE:CW) entered a partnership with Averna to develop custom aerospace test systems, integrating advanced testing technology into its production process. The company secured a multi-year U.S. Department of Defense contract to supply shipboard helicopter handling systems, including RAST technology, to the U.S. Naval Air Warfare Center. Curtiss-Wright operates at the intersection of aerospace and defense hardware, supplying mission-critical systems to original equipment...